Phase 2 Data Highlight Roflumilast Cream in Infant AD – Dermatology Times

eczemarelief
9 months ago
Share



Phase 2 Data Highlight Roflumilast Cream in Infant AD  Dermatology Times



Source link

Tags: Cream, data, Dermatology, highlight, infant, Phase, Roflumilast, Times
Leave a Comment
Previous Article
Amgen Lawsuit And Eczema Drug Exit Reframe Risk And R&D Priorities – simplywall.st
Next Article
Amgen Drops Eczema Drug Pact As Investors Weigh R&D Focus And Valuation – simplywall.st

You Might also Like

Delgocitinib Cream Projected to Save US Health Plans Millions for Chronic Hand Eczema – AJMC
eczemarelief July 28, 2026
Topical steroid cream withdrawal left man with eczema 'bedridden' – BBC
eczemarelief July 26, 2026
BREAKING: US FDA Sets PDUFA for Roflumilast Cream 0.05% in Infants With AD – The Dermatology Digest
eczemarelief July 8, 2026
Post Comment